| Product Code: ETC9692229 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Pharmacogenetic Testing Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Thailand Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Thailand Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Thailand Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Thailand Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Thailand Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Thailand Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Thailand Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Thailand Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Thailand Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and adoption of personalized medicine in Thailand |
4.2.2 Growing prevalence of chronic diseases in the country |
4.2.3 Strong government support and initiatives to promote pharmacogenetic testing |
4.3 Market Restraints |
4.3.1 High initial costs associated with pharmacogenetic testing |
4.3.2 Limited availability of skilled professionals in the field |
4.3.3 Regulatory challenges and lack of clear guidelines for pharmacogenetic testing in Thailand |
5 Thailand Pharmacogenetic Testing Market Trends |
6 Thailand Pharmacogenetic Testing Market, By Types |
6.1 Thailand Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Thailand Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Thailand Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Thailand Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Thailand Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Thailand Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Thailand Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Thailand Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Thailand Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Thailand Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Thailand Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Thailand Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Thailand Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Thailand Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Thailand Pharmacogenetic Testing Market Export to Major Countries |
7.2 Thailand Pharmacogenetic Testing Market Imports from Major Countries |
8 Thailand Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare facilities offering pharmacogenetic testing services in Thailand |
8.2 Percentage of physicians trained in pharmacogenetic testing practices |
8.3 Rate of reimbursement for pharmacogenetic testing by health insurance providers |
9 Thailand Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Thailand Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Thailand Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Thailand Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Thailand Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Thailand Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Thailand Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Thailand Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Thailand Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Thailand Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Thailand Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here